Scientific Review and Monitoring Committee

The Scientific Review and Monitoring Committee (SRMC) provides the critical review of scientific merit, methodology and validity of statistical analyses of cancer-relevant studies prior to activation. The committee will ensure proper prioritization of studies and the ability to monitor all cancer-related studies for expected progress relating to accrual goals and performance standards.

The SRMC has the authority and charge to close any study not meeting the expected accrual goals or trials that have become obsolete by new advances in the field and therefore whose scientific rationale has become superseded by clinical practice. For a protocol to be reviewed by the SRMC, both the sponsoring Disease Site Group (DSG) and/or Research Program (RP) must provide endorsement.

Committee Decisions

Following discussion, the Committee votes to Approve, Approve with Stipulations, Table or Disapprove the protocol, meaning:

  • Approved: Approved for opening to accrual contingent upon obtaining IRB approval and completion of all other protocol activation steps
  • Approved with Stipulations: Study is approvable pending satisfactory responses to reviewer questions and concerns. The initial reviewers will review the PI response to stipulations, and the SRMC Chair or a Co-Chair will provide final approval.
  • Tabled: Substantial issues are present and revisions and/or formal reconsideration by SRMC are required.
  • Disapproved: The study is not approved for opening.

Important Documents


For information related to the SRMC, please contact the SRMC Administrative team at

Submission Deadlines for SRMC

The SRMC comprises two panels that each meet twice per month: the Biomedical Sciences Panel (BMSP) and the Cancer Control and Population Sciences Panel (CCPSP). The meetings are held virtually.

Frequently Asked Questions

SRMC BMSP Membership List

name role specialty/expertise
Ryan M. Thomas, M.D. Chair GI Surgery and Microbiome Biorepository
Michael Weaver, Ph.D., R.N. V-Chair Population Sciences & Biostatistics
Randal Henderson, M.D., MBA V-Chair Radiation Oncology
Frederic Kaye, M.D. V-Chair Thoracic Oncology
Elias Sayour, M.D., Ph.D. V-Chair Pediatric NeuroOnc
Karen Daily, D.O. Core Breast Oncology
Coy Heldermon, M.D., Ph.D. Core Breast Oncology
Petr Starostik, M.D. Core Pathology & Genetics
John Hiemenz, M.D. Core Hematologic Malignancies
Joanne Lagmay, M.D. Core Pediatric Oncology
David DeRemer, Pharm.D. Core Pharmacodynamics & Drug Development
Ji-Hyun Lee, DrPH Core Biostatistics
Shu Wang, Ph.D. Core Biostatistics
Karen Miller, JD Core Patient Advocate
Nosha Farhadfar, M.D. Core Hematologic Malignancies
Zhanna Galochkina, MS Core Biostatistics
Aaron Franke, M.D. Core Thoracic
Bently Doonan, M.D. Core Cutaneous

SRMC CCPSP Membership List

name role specialty/expertise
Michael Weaver, Ph.D., R.N. Chair Population Sciences & Biostatistics
Janice Krieger, Ph.D. Core Patient Communications & Decision Making
Deidre Pereira, Ph.D. Core Psychosocial & Biobehavioral Interventions
Carmen Bylund, Ph.D., FACH Core Survivorship
Georges Khalil, Ph.D. Core Cancer Prevention, Health Communication
Yingwei Yao, Ph.D. Core Biostatistics
Yi Guo, Ph.D. Core Biostatistics, Social Media & Big Data
Karen Miller, JD Core Citizen Scientist
Latrina Massey, MPH Core Community Outreach and Engagement